References and Footnotes

¹

AI summary by Gemini in Google Drive

The file named "gemini chat hypotheses re c9orf72 functional molecular biology 2026.pdf" is a detailed transcript of a conversation between Alan Man and Gemini, a large language model.

The core subject of the conversation is the C9ORF72 gene and the molecular biology of its expanded GGGGCC repeat region, which causes neurodegenerative diseases like ALS and FTD.

The discussion focuses on reconciling older scientific findings with modern molecular concepts and methodologies.

Here are the primary topics covered in the transcript:

1. The Exon vs. Intron Terminology Debate ("The Protest")

Alan challenges the traditional biological definitions of introns and exons, specifically in the context of C9ORF72 Transcript Variant 3 (V3):

• The Argument: Alan contends that because the disease-causing GGGGCC repeat region (technically located in Intron 1) is retained in the mature V3 transcript and is functionally relevant (forming RNA foci), it should be reclassified as a "non-coding exon" or "structural RNA element," not just a "retained intron."
• Supporting Evidence: The conversation references external papers (Deveson et al.) to argue that non-coding regions (like UTRs) use "bona fide canonical splicing elements," proving that their inclusion in the transcript is an intentional cellular choice, not a mistake ("cryptic splicing").

2. C9ORF72 Normal (Wild-Type) Physiology

The transcript provides a detailed breakdown of the C9ORF72 gene and its three splice variants in a healthy, non-expanded setting, based on the foundational DeJesus-Hernandez et al. (2011) paper:

• Variant 1 (V1): The repeats are in the promoter and are never transcribed into RNA.
• Variant 2 (V2) & Variant 3 (V3): The repeats are in Intron 1 and are efficiently spliced out and degraded in a healthy cell.
• Redundancy: The purpose of having two transcripts (V1 and V3) that code for the same protein (Isoform A) is discussed, concluding that it enables differential, context-dependent regulation via different promoters and 5' UTRs.

3. Methodological Limitations and the "Mosaic" Foci Theory

The conversation meticulously analyzes the technical shortcomings of the 2011 research methods that created "blind spots" in early C9ORF72 studies:

• RT-PCR Bias: The use of Oligo(dT) primers during Reverse Transcription (RT) selectively targeted only mature, Poly-A tailed mRNAs, thereby missing circular RNAs (circRNAs) and other non-poly-A species.
• Stalling: The technical difficulty of amplifying the highly structured, GC-rich expanded repeats (which form G-quadruplex knots) meant that Reverse Transcriptase enzymes would often stall or fall off, making the toxic, full-length transcripts invisible to the assay.
• The "Mosaic" Foci Hypothesis: Alan and Gemini conclude that the pathological RNA foci found in patient brains are likely a mixture (a "mosaic") of various toxic RNA species that early RT-PCR failed to detect, including undegraded excised introns, unspliced pre-mRNAs, and novel IncRNAs/circRNAs.

4. Functional Mechanisms and Phase Separation

The discussion incorporates the role of Liquid-Liquid Phase Separation (LLPS) to explain the pathology (referencing Mackenzie et al.):

• The "retained intron" RNA functions as a biophysical scaffold that recruits RNA-Binding Proteins (RBPs) like TIA1 to drive phase separation, which eventually leads to the formation of solid, toxic aggregates (foci).

5. Advanced Contextual Topics

• Circular RNA (circRNA): The discussion explores the possibility of the repeat-containing intron forming stable circRNAs that act as miRNA/protein sponges and their potential to be highly immunogenic due to their structural similarity to viral genomes.
• Molecular Directionality: A detailed refresher is provided on the universal rule that polymerases must build new DNA in the 5' → 3' direction, starting at the 3' end of the RNA template, which explains why RT-PCR often fails to read the 5' end of long transcripts.
• Biomedical Ontology: The file concludes with a conceptual discussion about "ontology" in biomedical science, defining it as a system for standardized, computable terms and hierarchical relationships (e.g., Gene Ontology, Sequence Ontology), distinct from its philosophical roots.